Five-year Incidence of Age-related Macular Degeneration in the Central Region of Portugal

Age-Related Macular Degeneration Clinical Trial

— AMDIncidencePT  

Official title:

Five-year Incidence of Age-related Macular Degeneration in the Central Region of Portugal

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02748824
• Other study ID #: 4C-2016-09
• Secondary ID: AMDIncidence-CPT
• Status: Completed
• Phase: N/A
• First received: April 20, 2016
• Last updated: November 7, 2017
• Start date: July 2016
• Est. completion date: October 31, 2017

Study information

• Verified date: November 2017
• Source: Association for Innovation and Biomedical Research on Light and Image
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To assess the five-year incidence of AMD in a population from the central region of Portugal, previously phenotypically characterized.

Description:

Subjects who participated in the Epidemiologic Coimbra Eye Study (NCT01298674) between 2009 and 2013 will attend a single visit, after giving informed consent.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 5996
• Est. completion date: October 31, 2017
• Est. primary completion date: September 18, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

• Subjects who participated in the Epidemiologic Coimbra Eye Study (NCT01298674) and that were phenotyped;

• Subjects capable of understanding the information about the study and to give their informed consent to enter the study;

• Subjects willing and able to comply with the study procedures.

Exclusion Criteria:

• Not applicable

Related Conditions & MeSH terms

• Age-Related Macular Degeneration
• Macular Degeneration

Locations

Country	Name	City	State
Portugal	AIBILI/CEC - Centro Ensaios Clínicos	Coimbra

Sponsors (1)

Lead Sponsor	Collaborator
Association for Innovation and Biomedical Research on Light and Image

Country where clinical trial is conducted

Portugal, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Phenotypic classification of AMD in the five-year clinical visit. Comparison of this classification with the grading of 5 years ago.		5 years
Secondary	Risk factors: Demographic, Medical history, Ophthalmologic history, Family history of AMD, Systemic comorbidities and medication, Nutritional and Lifestyle habits. Signs of AMD on the multimodal evaluation.		5 years